These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 21666690)

  • 21. In contrast to other species, α-Galactosylceramide (α-GalCer) is not an immunostimulatory NKT cell agonist in horses.
    Dossa RG; Alperin DC; Garzon D; Mealey RH; Brown WC; Jervis PJ; Besra GS; Cox LR; Hines SA
    Dev Comp Immunol; 2015 Mar; 49(1):49-58. PubMed ID: 25445911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers.
    Benlagha K; Weiss A; Beavis A; Teyton L; Bendelac A
    J Exp Med; 2000 Jun; 191(11):1895-903. PubMed ID: 10839805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-Function Implications of the Ability of Monoclonal Antibodies Against α-Galactosylceramide-CD1d Complex to Recognize β-Mannosylceramide Presentation by CD1d.
    Clark K; Yau J; Bloom A; Wang J; Venzon DJ; Suzuki M; Pasquet L; Compton BJ; Cardell SL; Porcelli SA; Painter GF; Zajonc DM; Berzofsky JA; Terabe M
    Front Immunol; 2019; 10():2355. PubMed ID: 31649670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural determination of lipid antigens captured at the CD1d-T-cell receptor interface.
    Brennan PJ; Cheng TY; Pellicci DG; Watts GFM; Veerapen N; Young DC; Rossjohn J; Besra GS; Godfrey DI; Brenner MB; Moody DB
    Proc Natl Acad Sci U S A; 2017 Aug; 114(31):8348-8353. PubMed ID: 28716901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis, and functional activity of labeled CD1d glycolipid agonists.
    Jervis PJ; Polzella P; Wojno J; Jukes JP; Ghadbane H; Garcia Diaz YR; Besra GS; Cerundolo V; Cox LR
    Bioconjug Chem; 2013 Apr; 24(4):586-94. PubMed ID: 23458425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vβ2 natural killer T cell antigen receptor-mediated recognition of CD1d-glycolipid antigen.
    Patel O; Pellicci DG; Uldrich AP; Sullivan LC; Bhati M; McKnight M; Richardson SK; Howell AR; Mallevaey T; Zhang J; Bedel R; Besra GS; Brooks AG; Kjer-Nielsen L; McCluskey J; Porcelli SA; Gapin L; Rossjohn J; Godfrey DI
    Proc Natl Acad Sci U S A; 2011 Nov; 108(47):19007-12. PubMed ID: 22065767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural variations at position 93 of the invariant Vα24-Jα18 α chain of human iNKT-cell TCRs strongly impact on CD1d binding.
    Sanderson JP; Waldburger-Hauri K; Garzón D; Matulis G; Mansour S; Pumphrey NJ; Lissin N; Villiger PM; Jakobsen B; Faraldo-Gómez JD; Gadola SD
    Eur J Immunol; 2012 Jan; 42(1):248-55. PubMed ID: 21956730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
    Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
    J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Role of Adaptor Proteins in the Biology of Natural Killer T (NKT) Cells.
    Gerth E; Mattner J
    Front Immunol; 2019; 10():1449. PubMed ID: 31293596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tailored design of NKT-stimulatory glycolipids for polarization of immune responses.
    Hung JT; Huang JR; Yu AL
    J Biomed Sci; 2017 Mar; 24(1):22. PubMed ID: 28335781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The V alpha 14 NKT cell TCR exhibits high-affinity binding to a glycolipid/CD1d complex.
    Sidobre S; Naidenko OV; Sim BC; Gascoigne NR; Garcia KC; Kronenberg M
    J Immunol; 2002 Aug; 169(3):1340-8. PubMed ID: 12133957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of human invariant natural killer T cells with a thioglycoside analogue of α-galactosylceramide.
    Hogan AE; O'Reilly V; Dunne MR; Dere RT; Zeng SG; O'Brien C; Amu S; Fallon PG; Exley MA; O'Farrelly C; Zhu X; Doherty DG
    Clin Immunol; 2011 Aug; 140(2):196-207. PubMed ID: 21493160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural evaluation of potent NKT cell agonists: implications for design of novel stimulatory ligands.
    Schiefner A; Fujio M; Wu D; Wong CH; Wilson IA
    J Mol Biol; 2009 Nov; 394(1):71-82. PubMed ID: 19732779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Presentation of alpha-galactosylceramide by murine CD1d to natural killer T cells is facilitated by plasma membrane glycolipid rafts.
    Lang GA; Maltsev SD; Besra GS; Lang ML
    Immunology; 2004 Jul; 112(3):386-96. PubMed ID: 15196206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes.
    Nishimura T; Kitamura H; Iwakabe K; Yahata T; Ohta A; Sato M; Takeda K; Okumura K; Van Kaer L; Kawano T; Taniguchi M; Nakui M; Sekimoto M; Koda T
    Int Immunol; 2000 Jul; 12(7):987-94. PubMed ID: 10882410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The hypervariable region 4 (HV4) and position 93 of the α chain modulate CD1d-glycolipid binding of iNKT TCRs.
    Paletta D; Fichtner AS; Hahn AM; Starick L; Beyersdorf N; Monzon-Casanova E; Mueller TD; Herrmann T
    Eur J Immunol; 2015 Jul; 45(7):2122-33. PubMed ID: 25900449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conserved and heterogeneous lipid antigen specificities of CD1d-restricted NKT cell receptors.
    Brigl M; van den Elzen P; Chen X; Meyers JH; Wu D; Wong CH; Reddington F; Illarianov PA; Besra GS; Brenner MB; Gumperz JE
    J Immunol; 2006 Mar; 176(6):3625-34. PubMed ID: 16517731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Invariant TCR rather than CD1d shapes the preferential activities of C-glycoside analogues against human versus murine invariant NKT cells.
    Li X; Shiratsuchi T; Chen G; Dellabona P; Casorati G; Franck RW; Tsuji M
    J Immunol; 2009 Oct; 183(7):4415-21. PubMed ID: 19734232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD1d-independent activation of mouse and human iNKT cells by bacterial superantigens.
    Hayworth JL; Mazzuca DM; Maleki Vareki S; Welch I; McCormick JK; Haeryfar SM
    Immunol Cell Biol; 2012 Aug; 90(7):699-709. PubMed ID: 22041925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A structural basis for selection and cross-species reactivity of the semi-invariant NKT cell receptor in CD1d/glycolipid recognition.
    Kjer-Nielsen L; Borg NA; Pellicci DG; Beddoe T; Kostenko L; Clements CS; Williamson NA; Smyth MJ; Besra GS; Reid HH; Bharadwaj M; Godfrey DI; Rossjohn J; McCluskey J
    J Exp Med; 2006 Mar; 203(3):661-73. PubMed ID: 16505140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.